Minnesota v. Sanofi-Aventis U.S. LLC
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Commonwealth of Pennsylvania v. UPMC et al.
District Court: Commonwealth Court of Pennsylvania Status: Pending
In February 2019, Pennsylvania Attorney General Josh Shapiro stepped in to intervene in the long-standing battle over market share between University of Pittsburgh Medical Center (UPMC) and …
People of the State of California ex rel. Xavier Becerra v. Sutter Health
District Court: Superior Court of California, County of San Francisco Status: Decided
On March 29, 2018, California’s attorney general filed an antitrust and unfair competition lawsuit against Sutter Health alleging that Sutter engaged in “all-or-nothing” contracts with …
Sentry Data Sys. v. CVS Health
District Court: S.D. Florida Status: Pending
340B administrator Sentry Data Systems sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as …
In re: Flonase Antitrust Litigation
District Court: Eastern District of Pennsylvania Status: Pending
On December 22, 2017, the U.S. Court of Appeals for the Third Circuit ruled that an antitrust suit filed by Louisiana’s Attorney General against GlaxoSmithKline …
Federal Trade Commission v. Actavis, Inc.
District Court: Northern District of Georgia Status: Decided
The Supreme Court ruled in favor of the FTC, holding that a brand name manufacturer’s payment to a generic competitor to settle patent infringement claims …
Federal Trade Commission v. Allergan and Watson Laboratories, Inc. et al.
District Court: Northern District of California Status: Decided
On January 23, 2017, the FTC refiled a complaint against Watson Laboratories and its former parent company, Allergan, for entering a pay-for-delay settlement with EndoPharmaceuticals to block a generic version of …
Walgreen Co. et al v. Allergan, Inc
District Court: Eastern District of New York Status: Pending
Four drug retailers, including Walgreens and Albertsons, filed an antitrust suit alleging that Allergan devised and carried out a multifaceted and anticompetitive scheme to maintain …
Drogueria Betances LLC v. Novartis Pharmaceuticals Corp.
District Court: Southern District of New York Status: Pending
Novartis Pharmaceuticals Corp. allegedly agreed with Par Pharmaceuticals Inc. to squelch generic competition to Novartis’s hypertension drug Exforge, resulting in buyers paying millions more than …
Federal Trade Commission v. AbbVie Inc. et al.
District Court: Eastern District of Pennsylvania Status: Decided
FTC alleged AbbVie sued generic companies for patent infringement over their proposed generic version of the testosterone gel, AndroGel, without justifiable grounds but merely to …
In the Matter of Impax Laboratories Inc.
District Court: Federal Trade Commission Status: Pending
The Federal Trade Commission sued generic drugmaker Impax Laboratories Inc. for allegedly accepting more than $100 million to delay its release of a generic version …
In Re: Generic Pharmaceuticals Pricing Antitrust Litigation
District Court: Eastern District of Pennsylvania Status: Pending
Plaintiffs are attorney generals from 48 states, Puerto Rico, and the District of Columbia, as well as classes of private plaintiffs that filed an antitrust …
In re: EPIPEN (Epinephrine Injection, USP) Marketing, Sales Practices, and Antitrust Litigtion
District Court: District of Kansas Status: Pending
The plaintiffs in the case allege Mylan N.V. created and exploited an EpiPen monopoly by providing aggressive rebates and incentives to pharmacy benefit managers to …
In the Matter of ProMedica Health System, Inc.
District Court: United States of America Before The Federal Trade Commission Status: Decided
On April 22, 2014, the Sixth Circuit affirmed the FTC administrative order requiring ProMedica Health System of Toledo, OH, to divest acquired hospital St. Luke’s. The FTC …
Colleen Eastman, et al. v. Quest Diagnostics
District Court: N.D. California, San Francisco Division Status: Decided
A proposed class of patients accusing Quest Diagnostics of maintaining a lab service monopoly argued on appeal in the 9th Circuit on November 15, 2017 …
Shire US, Inc. v. Allergan, Inc. et al.
District Court: District of New Jersey Status: Pending
On October 2, 2017, Shire filed a complaint in New Jersey district court accusing Allergan of violating federal and state antitrust laws by improperly discounting …